These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2981095)

  • 1. B cell subsets in spleens of BALB/c mice: identification and isolation of MMTV-expressing and MMTV-responding subpopulations.
    Lopez DM; Charyulu V; Paul RD
    J Immunol; 1985 Jan; 134(1):603-7. PubMed ID: 2981095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subset of spleen lymphocytes from BALB/cCrgl mice stimulated by mouse mammary tumor virus.
    Lopez DM; Charyulu V; Sigel MM
    Cancer Res; 1981 Mar; 41(3):813-8. PubMed ID: 6257384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfer of endogenous retroviral superantigen from donor to recipient B cells following priming to induce peripheral T cell tolerance.
    Modlin CS; Todd GT; Cohen TD; Fairchild RL
    Cell Immunol; 1995 Sep; 164(2):217-26. PubMed ID: 7656330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of natural killer cells by mouse mammary tumor virus C4 in BALB/c and T-cell receptor V beta 2-transgenic mice.
    Gill R; Wang H; Bluethmann H; Iglesias A; Wei WZ
    Cancer Res; 1994 Mar; 54(6):1529-35. PubMed ID: 8137259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mammary cancer stages in BALB/cV mice: mouse mammary tumor virus expression and virus-host interactions.
    Slagle BL; Medina D; Butel JS
    J Natl Cancer Inst; 1987 Aug; 79(2):323-35. PubMed ID: 3037152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recipient polyclonal B cell activation and immunoglobulin production induced by priming with a retroviral superantigen.
    Modlin CS; Muruve NA; Stanko D; Caulfield MJ; Fairchild RL
    Cell Immunol; 1996 May; 169(2):252-63. PubMed ID: 8620553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of retroviral superantigen and products of the envelope gene from endogenous mouse mammary tumor virus in B cells from BALB/c mice.
    Lopez-Cepero M; Wang Y; Keydar I; Brandt-Carlson C; Butel JS; Lopez DM
    Cell Immunol; 1995 Jul; 163(2):191-7. PubMed ID: 7606792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic determinants in a virus-induced mouse mammary tumor recognized by cell-mediated immune assays.
    Lopez PF; Parks WP; Lopez DM
    J Natl Cancer Inst; 1984 Mar; 72(3):725-32. PubMed ID: 6199544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of viral antigens released into plasma and culture fluids by murine mammary tumor cells.
    Ritzi EM; Smith BA; Stolfi RL; Martin DS
    Cancer Res; 1981 Oct; 41(10):3885-90. PubMed ID: 6269731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B and T cells are required for mouse mammary tumor virus spread within the mammary gland.
    Golovkina TV; Dudley JP; Ross SR
    J Immunol; 1998 Sep; 161(5):2375-82. PubMed ID: 9725233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cells bearing Vbeta8 are preferentially infected with exogenous mouse mammary tumor virus.
    Upragarin N; Nishimura H; Wajjwalku W; Ando Y; Nagafuchi S; Watanabe T; Yoshikai Y
    J Immunol; 1997 Sep; 159(5):2189-95. PubMed ID: 9278306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dependence of initiation of an innocent bystander cytotoxicity reaction on the association of viral antigens and tumor cell membranes in mice.
    Lopez DM; Lopez PF; Parks WP; Paul RD
    J Natl Cancer Inst; 1986 May; 76(5):923-31. PubMed ID: 2871214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of CD28 costimulation in immune-mediated responses against mouse mammary tumor viruses.
    Palmer LD; Saha B; Hodes RJ; Abe R
    J Immunol; 1996 Mar; 156(6):2112-8. PubMed ID: 8690899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the effector cells mediating an "innocent bystander" cytotoxicity reaction induced by a syngeneic mammary adenocarcinoma in mice.
    Paul RD; Padmanabhan R; Lopez DM
    Cancer Res; 1984 Oct; 44(10):4480-6. PubMed ID: 6467207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of a V beta 2-specific superantigen with a tumorigenic milk-borne mouse mammary tumor virus.
    Hodes RJ; Novick MB; Palmer LD; Knepper JE
    J Immunol; 1993 Feb; 150(4):1422-8. PubMed ID: 8094408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse mammary tumor virus (MMTV) antigen(s) are present on B lymphocytes of BALB/c mice.
    Charyulu V; Sigel MM; Durden DL; Lopez DM
    Int J Cancer; 1979 Dec; 24(6):813-8. PubMed ID: 94593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strain-specific expression of spliced MMTV RNAs containing the superantigen gene.
    Xu L; Wrona TJ; Dudley JP
    Virology; 1997 Sep; 236(1):54-65. PubMed ID: 9299617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of mammary tumor progression on phenotype and function of spleen and in situ lymphocytes in mice.
    Buessow SC; Paul RD; Lopez DM
    J Natl Cancer Inst; 1984 Jul; 73(1):249-55. PubMed ID: 6610791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell deletion induced by chronic infection with mouse mammary tumor virus spares a CD25-positive, IL-10-producing T cell population with infectious capacity.
    Papiernik M; do Carmo Leite-de-MoraesM ; Pontoux C; Joret AM; Rocha B; Penit C; Dy M
    J Immunol; 1997 May; 158(10):4642-53. PubMed ID: 9144476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intervention of T-cells in transportation of mouse mammary tumor virus (milk factor) to mammary gland cells in vivo.
    Tsubura A; Inaba M; Imai S; Murakami A; Oyaizu N; Yasumizu R; Ohnishi Y; Tanaka H; Morii S; Ikehara S
    Cancer Res; 1988 Nov; 48(22):6555-9. PubMed ID: 2846153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.